Curis CRIS
NASDAQ CRIS
$0.39 -0.01 (-2.26%)
As of: Oct 21, 2026 · 1:01 PM EDT

Curis (CRIS) EV to EBITDA (2012)

Updated

Curis' (CRIS) EV to EBITDA stood at 115.95 in Q3 2012, down 20.3% from the prior quarter.

Analysis

Curis (CRIS) EV to EBITDA (2012) Analysis & Trends

On a TTM basis, Curis' EV to EBITDA came in at 64.96 as of Sep 30, 2012.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn
10 Curis 834,284.87 -33.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 115.95
Jun 30, 2012 145.47
Mar 31, 2012 748.89
API Access

Curis EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CRIS&period=max&api_key=YOUR_API_KEY